IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Glaxosmithkline

CUSIP: 3773W105 | 1 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Kahn Brothers Group Inc632,040
5.0% of portfolio›$27.4M
StyleTurnoverLocationFiled
Kahn Brothers Group Inc
632,040$27.4M5.0%Deep ValueLowNew York, NY2016-11-01